KR20170076756A - 전달 시스템 - Google Patents

전달 시스템 Download PDF

Info

Publication number
KR20170076756A
KR20170076756A KR1020177014273A KR20177014273A KR20170076756A KR 20170076756 A KR20170076756 A KR 20170076756A KR 1020177014273 A KR1020177014273 A KR 1020177014273A KR 20177014273 A KR20177014273 A KR 20177014273A KR 20170076756 A KR20170076756 A KR 20170076756A
Authority
KR
South Korea
Prior art keywords
yarn
coating
active compound
length
active
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
KR1020177014273A
Other languages
English (en)
Korean (ko)
Inventor
데이비드 앤더슨
조던 쉰들러
에릭 스캇 괴벨
Original Assignee
텍스타일-베이스드 딜리버리, 인코포레이티드
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 텍스타일-베이스드 딜리버리, 인코포레이티드 filed Critical 텍스타일-베이스드 딜리버리, 인코포레이티드
Publication of KR20170076756A publication Critical patent/KR20170076756A/ko
Abandoned legal-status Critical Current

Links

Images

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/12—Ketones
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/12—Ketones
    • A61K31/122—Ketones having the oxygen directly attached to a ring, e.g. quinones, vitamin K1, anthralin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/20—Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids
    • A61K31/203—Retinoic acids ; Salts thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/34—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having five-membered rings with one oxygen as the only ring hetero atom, e.g. isosorbide
    • A61K31/343—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having five-membered rings with one oxygen as the only ring hetero atom, e.g. isosorbide condensed with a carbocyclic ring, e.g. coumaran, bufuralol, befunolol, clobenfurol, amiodarone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/4164—1,3-Diazoles
    • A61K31/4166—1,3-Diazoles having oxo groups directly attached to the heterocyclic ring, e.g. phenytoin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/4412—Non condensed pyridines; Hydrogenated derivatives thereof having oxo groups directly attached to the heterocyclic ring
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/555—Heterocyclic compounds containing heavy metals, e.g. hemin, hematin, melarsoprol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/57—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone
    • A61K31/573—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone substituted in position 21, e.g. cortisone, dexamethasone, prednisone or aldosterone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/60—Salicylic acid; Derivatives thereof
    • A61K31/612—Salicylic acid; Derivatives thereof having the hydroxy group in position 2 esterified, e.g. salicylsulfuric acid
    • A61K31/616—Salicylic acid; Derivatives thereof having the hydroxy group in position 2 esterified, e.g. salicylsulfuric acid by carboxylic acids, e.g. acetylsalicylic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/32—Macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. carbomers, poly(meth)acrylates, or polyvinyl pyrrolidone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/34—Macromolecular compounds obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyesters, polyamino acids, polysiloxanes, polyphosphazines, copolymers of polyalkylene glycol or poloxamers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0002—Galenical forms characterised by the drug release technique; Application systems commanded by energy
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0014—Skin, i.e. galenical aspects of topical compositions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A61K9/0024—Solid, semi-solid or solidifying implants, which are implanted or injected in body tissue
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0087—Galenical forms not covered by A61K9/02 - A61K9/7023
    • A61K9/0092—Hollow drug-filled fibres, tubes of the core-shell type, coated fibres, coated rods, microtubules or nanotubes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L15/00—Chemical aspects of, or use of materials for, bandages, dressings or absorbent pads
    • A61L15/16—Bandages, dressings or absorbent pads for physiological fluids such as urine or blood, e.g. sanitary towels, tampons
    • A61L15/22—Bandages, dressings or absorbent pads for physiological fluids such as urine or blood, e.g. sanitary towels, tampons containing macromolecular materials
    • A61L15/24—Macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L15/00—Chemical aspects of, or use of materials for, bandages, dressings or absorbent pads
    • A61L15/16—Bandages, dressings or absorbent pads for physiological fluids such as urine or blood, e.g. sanitary towels, tampons
    • A61L15/22—Bandages, dressings or absorbent pads for physiological fluids such as urine or blood, e.g. sanitary towels, tampons containing macromolecular materials
    • A61L15/26—Macromolecular compounds obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L15/00—Chemical aspects of, or use of materials for, bandages, dressings or absorbent pads
    • A61L15/16—Bandages, dressings or absorbent pads for physiological fluids such as urine or blood, e.g. sanitary towels, tampons
    • A61L15/40—Bandages, dressings or absorbent pads for physiological fluids such as urine or blood, e.g. sanitary towels, tampons containing ingredients of undetermined constitution or reaction products thereof, e.g. plant or animal extracts
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L15/00—Chemical aspects of, or use of materials for, bandages, dressings or absorbent pads
    • A61L15/16—Bandages, dressings or absorbent pads for physiological fluids such as urine or blood, e.g. sanitary towels, tampons
    • A61L15/42—Use of materials characterised by their function or physical properties
    • A61L15/44—Medicaments
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M37/00—Other apparatus for introducing media into the body; Percutany, i.e. introducing medicines into the body by diffusion through the skin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/20—Hypnotics; Sedatives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/22—Anxiolytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/10—Antimycotics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2300/00—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
    • A61L2300/40—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices characterised by a specific therapeutic activity or mode of action
    • A61L2300/402—Anaestetics, analgesics, e.g. lidocaine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2300/00—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
    • A61L2300/40—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices characterised by a specific therapeutic activity or mode of action
    • A61L2300/404—Biocides, antimicrobial agents, antiseptic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2300/00—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
    • A61L2300/40—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices characterised by a specific therapeutic activity or mode of action
    • A61L2300/41—Anti-inflammatory agents, e.g. NSAIDs
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2300/00—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
    • A61L2300/40—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices characterised by a specific therapeutic activity or mode of action
    • A61L2300/43—Hormones, e.g. dexamethasone

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Hematology (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Materials Engineering (AREA)
  • Dermatology (AREA)
  • Biomedical Technology (AREA)
  • Neurosurgery (AREA)
  • Inorganic Chemistry (AREA)
  • Nanotechnology (AREA)
  • Neurology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Anesthesiology (AREA)
  • Zoology (AREA)
  • Botany (AREA)
  • Pain & Pain Management (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Medical Informatics (AREA)
  • Rheumatology (AREA)
  • Pulmonology (AREA)
  • Medicinal Preparation (AREA)
  • Materials For Medical Uses (AREA)
  • Polymers & Plastics (AREA)
  • Treatments For Attaching Organic Compounds To Fibrous Goods (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
KR1020177014273A 2014-10-30 2015-10-29 전달 시스템 Abandoned KR20170076756A (ko)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201462072896P 2014-10-30 2014-10-30
US62/072,896 2014-10-30
PCT/US2015/058059 WO2016069898A1 (en) 2014-10-30 2015-10-29 Delivery systems

Publications (1)

Publication Number Publication Date
KR20170076756A true KR20170076756A (ko) 2017-07-04

Family

ID=55851473

Family Applications (1)

Application Number Title Priority Date Filing Date
KR1020177014273A Abandoned KR20170076756A (ko) 2014-10-30 2015-10-29 전달 시스템

Country Status (10)

Country Link
US (7) US9669012B2 (enExample)
EP (1) EP3212173A4 (enExample)
JP (1) JP6896625B2 (enExample)
KR (1) KR20170076756A (enExample)
CN (1) CN107205956A (enExample)
AU (1) AU2015339203B2 (enExample)
BR (1) BR112017007942A2 (enExample)
CA (1) CA3003397A1 (enExample)
MX (1) MX2017005399A (enExample)
WO (1) WO2016069898A1 (enExample)

Families Citing this family (23)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2014160744A1 (en) * 2013-03-26 2014-10-02 Innovia Llc Pacemaker lead and other medical implant devices
CA3003397A1 (en) 2014-10-30 2016-05-06 Textile-Based Delivery, Inc. Delivery systems
US11690928B2 (en) * 2017-07-17 2023-07-04 Peter Rigg Fragrance delivery systems
WO2019094546A1 (en) * 2017-11-13 2019-05-16 Casey Nicole Warp yarn of woven textiles
US11883523B2 (en) 2018-09-18 2024-01-30 Mary Kay Inc. Plant extracts to reduce the appearance of hyperpigmented skin or to lighten skin
EP3666939B1 (en) 2018-12-12 2024-10-30 Aladdin Manufacturing Corporation A multifilament bundle of melt spun polymer filaments
IL294023A (en) * 2019-12-31 2022-08-01 Wanka Tanka Ltd Sustained release plastic compound
US20210259985A1 (en) * 2020-02-20 2021-08-26 WeDoWee, LLC Method of providing cbd oil within polymer fibrous structures for subsequent transfer to a user's skin
IT202000005515A1 (it) * 2020-03-16 2021-09-16 U Earth Biotech Ltd Maschera filtrante perfezionata
US12473667B2 (en) 2020-06-16 2025-11-18 Aladdin Manufacturing Corporation Systems and methods to provide color enhanced yarns
WO2021257739A1 (en) 2020-06-16 2021-12-23 Aladdin Manufacturing Corporation Systems and methods for producing a bundle of filaments and/or a yarn
CN115697872A (zh) 2020-06-16 2023-02-03 美国阿拉丁制造公司 用于生产长丝束和/或纱线的系统和方法
US12186512B2 (en) * 2020-10-26 2025-01-07 Christopher Green Treatment for dry eyes
US12029718B2 (en) 2021-11-09 2024-07-09 Cct Sciences, Llc Process for production of essentially pure delta-9-tetrahydrocannabinol
AU2022229531A1 (en) 2021-03-05 2023-08-17 H.B. Fuller Company Cyanoacrylate composition with hazardless stabilizer
IT202100006290A1 (it) 2021-03-16 2022-09-16 U Earth Biotech Ltd Una maschera facciale indossabile e configurata per filtrare l’aria inalata da un utente
IT202100006284A1 (it) 2021-03-16 2022-09-16 U Earth Biotech Ltd Mezzi di filtraggio di una maschera facciale indossabile
US20240191404A1 (en) * 2021-04-23 2024-06-13 Aladdin Manufacturing Corporation Method of manufacturing yarn and yarn obtained in that manner
WO2022238862A1 (en) * 2021-05-12 2022-11-17 Aladdin Manufacturing Corporation Fibers with active additives technical field
US20220372695A1 (en) * 2021-05-20 2022-11-24 Textile-Based Delivery, Inc. Active agent indicator for textiles
CN114045587B (zh) * 2021-11-10 2022-09-02 武汉纺织大学 基于亲水改性壳聚糖的复合纱线止血材料
US12245644B2 (en) * 2022-04-28 2025-03-11 Tamika MAYES Support garments
CN114959966B (zh) * 2022-07-15 2023-04-18 苏州赛恩环境科技有限公司 一种内注甲醛清除剂的纤维线生产设备及方法

Family Cites Families (85)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US1814853A (en) 1930-01-13 1931-07-14 Dow Chemical Co Method of purifying methyl salicylate
US2799598A (en) 1951-08-17 1957-07-16 Owens Corning Fiberglass Corp Process of forming coated twisted yarns and woven fabrics and resultant article
US3674901A (en) * 1966-07-26 1972-07-04 Nat Patent Dev Corp Surgical sutures
US3854480A (en) * 1969-04-01 1974-12-17 Alza Corp Drug-delivery system
US3845761A (en) * 1970-06-02 1974-11-05 Alza Corp Intrauterine contraceptive anti-fertility device for the management of reproduction
JPS4840924B1 (enExample) * 1970-09-26 1973-12-04
US3845791A (en) 1970-10-15 1974-11-05 Continental Can Co Universal filling head
BE789524A (fr) * 1971-09-30 1973-01-15 Alza Corp Dispositif de liberation de medicaments
US3948254A (en) 1971-11-08 1976-04-06 Alza Corporation Novel drug delivery device
GB1412970A (en) * 1974-01-15 1975-11-05 Schering Ag Pharmaceutical preparations containing silicone rubber
US3993072A (en) 1974-08-28 1976-11-23 Alza Corporation Microporous drug delivery device
US3992518A (en) * 1974-10-24 1976-11-16 G. D. Searle & Co. Method for making a microsealed delivery device
US4314557A (en) 1980-05-19 1982-02-09 Alza Corporation Dissolution controlled active agent dispenser
JPS6072550A (ja) * 1983-09-27 1985-04-24 日東電工株式会社 創傷カバ−剤
US4751133A (en) * 1984-11-13 1988-06-14 Thermedics, Inc. Medical patches and processes for producing same
US4638043A (en) * 1984-11-13 1987-01-20 Thermedics, Inc. Drug release system
US6040251A (en) * 1988-03-14 2000-03-21 Nextec Applications Inc. Garments of barrier webs
US5221722A (en) * 1988-11-28 1993-06-22 The B. F. Goodrich Company Crosslinked polyacrylic acid
EP0395476A3 (en) 1989-04-28 1992-01-08 Ricoh Kyosan Inc. Method and apparatus for the production of ionic cloths for use in ionic dressings
FR2664815B1 (fr) * 1990-07-23 1994-11-04 Adir Systeme matriciel autoadhesif pour la liberation prolongee du piribedil par voie transcutanee.
AU2699892A (en) 1991-10-04 1993-05-03 Gs Biochem Ab Particles, method of preparing said particles and uses thereof
US5353820A (en) * 1992-02-06 1994-10-11 Gillette Canada Inc. Flavored dental cleaning article and method
US5299335A (en) 1993-08-23 1994-04-05 Ivester Philip K Fragrance-releasing pillow and the like
US6103644A (en) * 1993-12-22 2000-08-15 Nordico Marketing Development, Inc. Impregnated matrix and method for making same
US5660848A (en) 1994-11-02 1997-08-26 The Population Council, Center For Biomedical Research Subdermally implantable device
CA2242753A1 (en) 1996-01-30 1997-08-07 Novagent Oy Composition for transdermal delivery of drugs
US6638621B2 (en) 2000-08-16 2003-10-28 Lyotropic Therapeutics, Inc. Coated particles, methods of making and using
US6020412A (en) * 1997-12-04 2000-02-01 Mitsubishi Polyester Film, Llc Controlled release coating comprising blend of silicone polymer and adhesion promoter
US5932617A (en) * 1998-02-06 1999-08-03 Woundfast Pharmaceuticals Inc. Wound-treating composition and method
JP2000096443A (ja) * 1998-09-25 2000-04-04 Toray Ind Inc 繊維布帛およびその製造方法
US5965137A (en) 1998-11-16 1999-10-12 Advanced Medical Instruments Insect repellent composition and method for inhibiting the transmission and treatment of symptoms of vector-borne diseases
JP2000212873A (ja) * 1999-01-18 2000-08-02 Nonogawa Shoji Kk 機能性繊維
AU6526100A (en) * 1999-08-06 2001-03-05 Board Of Regents, The University Of Texas System Drug releasing biodegradable fiber implant
US7033603B2 (en) 1999-08-06 2006-04-25 Board Of Regents The University Of Texas Drug releasing biodegradable fiber for delivery of therapeutics
US6158253A (en) * 1999-09-17 2000-12-12 Knit-Rite, Inc. Seamless, form fitting foot sock
JP2001097839A (ja) * 1999-09-28 2001-04-10 Shiseido Co Ltd 加齢臭抑制繊維および繊維処理剤
MXPA02006367A (es) * 1999-12-27 2002-11-29 Kimberly Clark Co Fibras que proporcionan entrega controlada de agente activo.
ATE466129T1 (de) * 2000-06-02 2010-05-15 Milliken & Co Garne und stoffe mit einer waschfesten, nicht- elektrisch leitenden, topisch aufgebrachten, auf metall basierenden beschichtung
AU2001282982B2 (en) * 2000-08-17 2007-01-04 Covidien Lp Sutures and coatings made from therapeutic absorbable glass
GB0024884D0 (en) 2000-10-11 2000-11-22 Astrazeneca Ab Method
JP2004514690A (ja) 2000-11-29 2004-05-20 リオトロピック　セラピュティックス　アイエヌシー． 薬剤の溶媒系
ES2240313T3 (es) 2000-12-07 2005-10-16 Warner-Lambert Company Llc Procedimiento y sistema para la liberacion uniforme de un farmaco.
AU2002259045B2 (en) 2001-04-26 2008-05-22 Psivida Us Inc. Sustained release drug delivery system containing codrugs
FR2826380B1 (fr) 2001-06-22 2007-03-16 Nathalie Chetboun Procede de traitement anti-acariens et anti-microbien des materiaux textiles par huile naturelle microencapsulee
CA2451432A1 (en) 2001-06-23 2003-01-03 Lyotropic Therapeutics, Inc. Particles with improved solubilization capacity
CN1320063C (zh) 2001-10-17 2007-06-06 三仪股份有限公司 抗菌性复合粒子和抗菌性树脂组合物
CA2468780A1 (en) * 2001-12-03 2003-06-12 C.R. Bard, Inc. Microbe-resistant medical device, microbe-resistant polymeric coating and methods for producing same
GB0130608D0 (en) 2001-12-21 2002-02-06 Psimedica Ltd Medical fibres and fabrics
MXPA04011004A (es) 2002-05-07 2005-01-25 Control Delivery Sys Inc Procesos para formar un dispositivo de administracion de farmaco.
US8871241B2 (en) 2002-05-07 2014-10-28 Psivida Us, Inc. Injectable sustained release delivery devices
AU2003287666A1 (en) 2002-11-13 2004-06-03 Control Delivery Systems, Inc. Systemic delivery of antiviral agents
JP2004195348A (ja) * 2002-12-18 2004-07-15 Akatsuki Kinzoku Kogyo:Kk 塗工シート加工装置および貼付剤
DE602004024190D1 (de) 2003-02-19 2009-12-31 Natrix Separations Inc Geträgerte poröse gele umfassende verbundmaterialien
MX296137B (es) * 2003-06-30 2012-02-13 Procter & Gamble Tramas de nanofibras recubiertas.
US7713440B2 (en) 2003-10-08 2010-05-11 Lyotropic Therapeutics, Inc. Stabilized uncoated particles of reversed liquid crystalline phase materials
DE102004037752A1 (de) * 2004-08-04 2006-03-16 Cognis Deutschland Gmbh & Co. Kg Ausgerüstete Fasern und textile Flächengebilde
US8048446B2 (en) 2005-05-10 2011-11-01 Drexel University Electrospun blends of natural and synthetic polymer fibers as tissue engineering scaffolds
WO2006127454A2 (en) 2005-05-23 2006-11-30 Appleton Papers Inc. Oil-in-water capsule manufacture process and microcapsules produced by such process
CN101232815A (zh) 2005-06-03 2008-07-30 巴斯福股份公司 用于浸渍纤维、织物和网状物而赋予抗害虫保护活性的组合物
CN1883438A (zh) 2005-06-21 2006-12-27 香港理工大学 温度响应性智能面膜及其制备方法
DE602006020063D1 (de) 2005-12-07 2011-03-24 Univ Ramot Wirkstoffabgebende verbundkörper
CA2636716C (en) 2006-01-13 2014-12-23 Surmodics, Inc. Microparticle containing matrices for drug delivery
US8968782B2 (en) 2006-06-28 2015-03-03 Surmodics, Inc. Combination degradable and non-degradable matrices for active agent delivery
JP2008057100A (ja) 2006-08-29 2008-03-13 Mmi-Ipco Llc 感温性且つ感湿性のスマートテキスタイル
TW200813289A (en) * 2006-09-08 2008-03-16 Albemarle Corp Flame retarded textile products and a method of making the same
US8277711B2 (en) 2007-03-29 2012-10-02 E I Du Pont De Nemours And Company Production of nanofibers by melt spinning
WO2009067242A2 (en) 2007-11-20 2009-05-28 Imclone Llc Co-crystal of antibody 11f8 fab fragment and egfr extracellular domain and uses thereof
US20090158492A1 (en) 2007-12-21 2009-06-25 Min Yao Quick-drying textile
AU2009204189B2 (en) * 2008-01-08 2014-01-16 Quick-Med Technologies, Inc. Disinfectant alcohol-soluble quaternary ammonium polymers
KR20110097923A (ko) 2008-12-05 2011-08-31 엘파스, 인크. 항-지질 항체 결정 구조를 이용한 항체 설계
US20110142898A1 (en) 2009-12-11 2011-06-16 Jerry Fan Devices for treatment of skin disorders
WO2011079232A1 (en) * 2009-12-23 2011-06-30 Psivida Us, Inc. Sustained release delivery devices
US9901128B2 (en) * 2009-12-24 2018-02-27 David A. Gray Antimicrobial apparel and fabric and coverings
US10111830B2 (en) 2010-03-16 2018-10-30 Titan Pharmaceuticals, Inc. Heterogeneous implantable devices for drug delivery
WO2011123723A1 (en) * 2010-03-31 2011-10-06 Enviroscent, Inc. Methods, compositions and articles for olfactory-active substances
RU2012146630A (ru) 2010-04-06 2014-05-20 Аллерган, Инк. Имплантаты в виде резервуаров с замедленным высвобождением для внутрикамерной доставки лекарственных средств
CN102247316B (zh) * 2011-08-16 2013-09-11 上海交通大学 一种控制药物释放的疏水涂层及其制备方法
US20140302249A1 (en) * 2011-08-31 2014-10-09 The University Of Akron Coated fibers exhibiting beads-on-a-string morphology
CA2849423A1 (en) * 2011-09-09 2013-03-14 Axxia Pharmaceuticals, Llc Silicone coated implants
US20150202161A1 (en) * 2012-08-20 2015-07-23 O-Ray Pharma, Inc. Process for manufacturing drug delivery formulations
US20140271863A1 (en) 2013-03-14 2014-09-18 Textile-Based Delivery, Inc. Hot washable poly-n-isopropylacrylamide hydrogel delivery systems
EP2971291A1 (en) * 2013-03-15 2016-01-20 Arsenal Medical, Inc. Core-sheath fibers and methods of making and using same
DE102014208253A1 (de) 2014-04-30 2015-11-05 MAHLE Behr GmbH & Co. KG Abgasanlage für ein Kraftfahrzeug
JP2017522365A (ja) 2014-05-30 2017-08-10 テクスタイル−ベイスド デリバリー，インコーポレイテッド 薬物送達システム及び関連する使用方法
CA3003397A1 (en) 2014-10-30 2016-05-06 Textile-Based Delivery, Inc. Delivery systems

Also Published As

Publication number Publication date
US20190105283A1 (en) 2019-04-11
CN107205956A (zh) 2017-09-26
AU2015339203B2 (en) 2020-12-24
US20200390720A1 (en) 2020-12-17
BR112017007942A2 (pt) 2017-12-19
JP2018503598A (ja) 2018-02-08
US20230255895A1 (en) 2023-08-17
WO2016069898A1 (en) 2016-05-06
US20170231919A1 (en) 2017-08-17
CA3003397A1 (en) 2016-05-06
AU2015339203A1 (en) 2017-04-20
JP6896625B2 (ja) 2021-06-30
US11690808B2 (en) 2023-07-04
US11633366B2 (en) 2023-04-25
EP3212173A4 (en) 2018-06-20
US20190038568A1 (en) 2019-02-07
US10799464B2 (en) 2020-10-13
EP3212173A1 (en) 2017-09-06
US9669012B2 (en) 2017-06-06
MX2017005399A (es) 2017-07-26
US20160120986A1 (en) 2016-05-05
US20230338301A1 (en) 2023-10-26

Similar Documents

Publication Publication Date Title
US20230338301A1 (en) Delivery systems
US20140271863A1 (en) Hot washable poly-n-isopropylacrylamide hydrogel delivery systems
CA2594407A1 (en) Device method, and use for treatment of neuropathy involving nitric oxide
WO2001026610A1 (en) Electrospun skin masks and uses thereof
JP2011520801A (ja) 皮膚病変を治療するためのオピオイド組成物
IT201900002767A1 (it) Presidio medico per la cura di patologie cutanee e relativo metodo di realizzazione
CN106400308A (zh) 一种自芳香天然抗菌除臭非织造布及其应用
US20220401376A1 (en) Delivery systems for release of active compounds
US20230404935A1 (en) Delivery systems
US20220175691A1 (en) Delivery systems for release of active compounds
WO2014089649A1 (pt) "nanofibras contendo substancia ativa com liberação controlada para aplicação odontológica e processo"
Shirvan et al. Allergies caused by textiles and their control
KR101696275B1 (ko) 색조화장이 가능한 나노케어 스팟패치 및 그 제조방법
CN215426220U (zh) 一种具有护肤功效的无纺布桑拿用品
CN212219481U (zh) 一种中药网格芯垫、口罩及生产装置
US20210363673A1 (en) Removable patch with active agent for textiles
CN1586633A (zh) 抗菌防感染卫生巾
DE10157124A1 (de) Mikrofaserhaltige Vorrichtung zur kontrollierten Freisetzung von Stoffen
Shaikh et al. Fabrication of biodegradable nano medical patches incorporating a sustained-release pharmacological agent using electro-spinning technique
EP4302744A1 (de) Hautauflage und verfahren zur herstellung einer hautauflage
CN207987377U (zh) 一种含金诃子的功能纤维
DE202022103727U1 (de) Hautauflage
CN111300913A (zh) 一种中药网格芯垫、口罩及生产装置
US20160143947A1 (en) SnF2 APPLICATIONS, METHODS AND RELATED FORMULATIONS
JP2004149430A (ja) 衛生用繊維製品およびそれを用いた衛生用品

Legal Events

Date Code Title Description
PA0105 International application

St.27 status event code: A-0-1-A10-A15-nap-PA0105

PG1501 Laying open of application

St.27 status event code: A-1-1-Q10-Q12-nap-PG1501

PA0201 Request for examination

St.27 status event code: A-1-2-D10-D11-exm-PA0201

E902 Notification of reason for refusal
PE0902 Notice of grounds for rejection

St.27 status event code: A-1-2-D10-D21-exm-PE0902

E13-X000 Pre-grant limitation requested

St.27 status event code: A-2-3-E10-E13-lim-X000

P11-X000 Amendment of application requested

St.27 status event code: A-2-2-P10-P11-nap-X000

P13-X000 Application amended

St.27 status event code: A-2-2-P10-P13-nap-X000

E701 Decision to grant or registration of patent right
PE0701 Decision of registration

St.27 status event code: A-1-2-D10-D22-exm-PE0701

PC1904 Unpaid initial registration fee

St.27 status event code: A-2-2-U10-U14-oth-PC1904

St.27 status event code: N-2-6-B10-B12-nap-PC1904